Home » Topics » BioWorld Science

BioWorld Science
RSS

PDE IV inhibitor selected for further study

June 14, 1996

Sankyo reveals PAF antagonists

June 14, 1996

LTB4 antagonists from Pfizer

June 14, 1996

Schering-Plough seeks Nasonex approval

June 14, 1996

Cypros conferred SBIR grant to develop CPC-111 prodrugs

June 14, 1996

Activase cleared by FDA for ischemic stroke

June 14, 1996

More glutamate antagonists from NeuroSearch

June 14, 1996

Novo Nordisk synthesizes AMPA antagonists

June 14, 1996

Glutamate antagonists reported by BASF

June 14, 1996

Colchicine/hydroxychloroquine therapy of AD

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...